A bill clearing the way for the use of psychedelics as mental health treatment has passed a key state legislative committee.
The bill, intended to “increase access to mental health drugs,” would license and fund three treatment sites dedicated to the use of MDMA, commonly known as ecstasy or “molly,” and psilocybin, the psychedelic substance in so-called “magic”. ” mushrooms for use against treatment-resistant post-traumatic stress disorder, depression and other mental health problems.
- Health ministers agree to tackle urgent health issues in the Americas at PAHO Directing Council – PAHO / WHO
- Parents worried about state health survey aimed at addressing youth health issues
- Virtual and hybrid collaboration of the Indonesian Embassy on environment and health issues
- Torquay man with mental health issues died of fatal overdose